NA Clinical Trial Imaging Market - Industry Trends and Forecast to 2029

NA Clinical Trial Imaging Market - Industry Trends and Forecast to 2029

North America clinical trial imaging market is projected to register a substantial CAGR of 8.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029

Market Segmentation

North America Clinical Trial Imaging Market, By Product & Services (Services and Software), Application (Oncology, Neurology, Cardiology, Endocrinology, Dermatology, Hematology, and Others), Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography, Nuclear Medicine, Optical Coherence Tomography, and Others), End User (Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Academic and Government Research Institutes, and Others), Distribution Channel (Direct Sales and Tender Sales), Country (U.S., Canada, and Mexico) Industry Trends and Forecast to 2029

Some of the major factors driving the market growth are:
• Increasing prevalence of cardiac disorders among the population

Market Players

The key market players operating in the North America clinical trial imaging market are listed below:
• Navitas Life Sciences
• Resonance health
• BioTelemetry, Inc
• IXICO plc
• ICON plc
• Image Core Lab
• Anagram 4 clinical trials
• Bioclinica
• Cardiovascular Imaging Technologies
• ERT Clinical
• INTrinsic Imaging
• Lyscaut Medical Imaging Company
• Parexel International Corporation
• Perspectum Diagnostics
• Quotient Sciences
• Radiant Sage LLC
• Worldcare ClinicalCompanies

• Navitas Life Sciences
• Resonance health
• BioTelemetry, Inc
• IXICO plc
• ICON plc
• Image Core Lab
• Anagram 4 clinical trials
• Bioclinica
• Cardiovascular Imaging Technologies
• ERT Clinical
• INTrinsic Imaging
• Lyscaut Medical Imaging Company
• Parexel International Corporation
• Perspectum Diagnostics
• Quotient Sciences
• Radiant Sage LLC
• Worldcare Clinical


Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of North America Clinical Trial Imaging Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Products And Services Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market Application Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter’s Five Forces
5 North America Clinical Trial Imaging Market: Regulations
6 Market Overview
6.1 Drivers
6.1.1 Rising R&D Expenditure
6.1.2 Increasing Number Of Contract Research Organizations (Cros)
6.1.3 Increasing Incidence Of Chronic Diseases
6.1.4 Growth In The Pharmaceutical And Imaging Industries
6.2 Restraints
6.2.1 High-risk Radiation Causing Diseases
6.2.2 High Implementation Cost Of Imaging Systems
6.3 Opportunities
6.3.1 Rise In Healthcare Expenditure
6.3.2 Strategic Initiatives By Key Players
6.3.3 Development Of Innovative Imaging Modalities And Contrast Agents
6.4 Challenges
6.4.1 Strict Regulatory Policies
6.4.2 Cost Of Clinical Trials
7 North America Clinical Trial Imaging Market, By Products & Services
7.1 Overview
7.2 Services
7.2.1 Operational Imaging Services
7.2.2 Read Analysis Services
7.2.3 Trial Design Consulting Services
7.2.4 System And Technical Support Services
7.3 Software
8 North America Clinical Trial Imaging Market, By Modality
8.1 Overview
8.2 Computed Tomography
8.3 Magentic Resonance Imaging
8.4 Echocardiography
8.5 Nuclear Medicine
8.6 Positron Emission Tomography
8.7 X-ray
8.8 Ultrasound
8.9 Optical Coherence Tomography
8.10 Others
9 North America Clinical Trial Imaging Market, By Application
9.1 Overview
9.2 Oncology
9.2.1 X-ray
9.2.2 Ultrasound
9.2.3 Computed Tomography
9.2.4 Magnetic Resonance Imaging
9.2.5 Nuclear Medicine
9.2.6 Positron Emission Tomography
9.2.7 Optical Coherence Tomography
9.2.8 Echocardiography
9.2.9 Others
9.3 Neurology
9.3.1 Computed Tomography
9.3.2 Magnetic Resonance Imaging
9.3.3 Positron Emission Tomography
9.3.4 Nuclear Medicine
9.3.5 X-ray
9.3.6 Ultrasound
9.3.7 Optical Coherence Tomography
9.3.8 Echocardiography
9.3.9 Others
9.4 Cardiology
9.4.1 Echocardiography
9.4.2 Magnetic Resonance Imaging
9.4.3 Computed Tomography
9.4.4 Positron Emission Tomography
9.4.5 Nuclear Medicine
9.4.6 X-ray
9.4.7 Ultrasound
9.4.8 Optical Coherence Tomography
9.4.9 Others
9.5 Endocrinology
9.5.1 Computed Tomography
9.5.2 Magnetic Resonance Imaging
9.5.3 Echocardiography
9.5.4 Positron Emission Tomography
9.5.5 Nuclear Medicine
9.5.6 X-ray
9.5.7 Ultrasound
9.5.8 Optical Coherence Tomography
9.5.9 Others
9.6 Dermatology
9.6.1 Ultrasound
9.6.2 X-ray
9.6.3 Magnetic Resonance Imaging
9.6.4 Computed Tomography
9.6.5 Optical Coherence Tomography
9.6.6 Positron Emission Tomography
9.6.7 Nuclear Medicine
9.6.8 Echocardiography
9.6.9 Others
9.7 Hematology
9.7.1 Ultrasound
9.7.2 Computed Tomography
9.7.3 Magnetic Resonance Imaging
9.7.4 X-ray
9.7.5 Positron Emission Tomography
9.7.6 Nuclear Medicine
9.7.7 Optical Coherence Tomography
9.7.8 Echocardiography
9.7.9 Others
9.8 Others
10 North America Clinical Trial Imaging Market, By End User
10.1 Overview
10.2 Contract Research Organization
10.3 Pharmaceutical And Biotechnology Companies
10.4 Medical Device Manufacturers
10.5 Academic And Government Research Institutes
10.6 Others
11 North America Clinical Trial Imaging Market, By Distributor
11.1 Overview
11.2 Direct Sales
11.3 Tender Sales
12 North America Clinical Trial Imaging Market, By Region
12.1 North America
12.1.1 U.S.
12.1.2 Canada
12.1.3 Mexico
13 North America Clinical Trial Imaging Market: Company Landscape
13.1 Company Share Analysis: North America
14 Swot Analysis
15 Company Profile
15.1 Navitas Life Sciences
15.1.1 Company Snapshot
15.1.2 Company Share Analysis
15.1.3 Product Portfolio
15.1.4 Recent Developments
15.2 Resonance Health Analytical Services
15.2.1 Company Snapshot
15.2.2 Revenue Analysis
15.2.3 Company Share Analysis
15.2.4 Product Portfolio
15.2.5 Recent Development
15.3 Clario
15.3.1 Company Snapshot
15.3.2 Company Share Analysis
15.3.3 Product Portfolio
15.3.4 Recent Developments
15.4 Paraxel
15.4.1 Company Snapshot
15.4.2 Company Share Analysis
15.4.3 Product Portfolio
15.4.4 Recent Development
15.5 Biotelemetry, A Philips Company
15.5.1 Company Snapshot
15.5.2 Company Share Analysis
15.5.3 Product Portfolio
15.5.4 Recent Development
15.6 Icon Plc
15.6.1 Company Snapshot
15.6.2 Revenue Analysis
15.6.3 Product Portfolio
15.6.4 Recent Developments
15.7 Median Technologies
15.7.1 Company Snapshot
15.7.2 Revenue Analysis
15.7.3 Product Portfolio
15.7.4 Recent Development
15.8 Perspectum
15.8.1 Company Snapshot
15.8.2 Product Portfolio
15.8.3 Recent Developments
15.9 Anagram 4 Clinical Trials
15.9.1 Company Snapshot
15.9.2 Product Portfolio
15.9.3 Recent Development
15.10 Calyx
15.10.1 Company Snapshot
15.10.2 Product Portfolio
15.10.3 Recent Development
15.11 Image Core Lab
15.11.1 Company Snapshot
15.11.2 Product Portfolio
15.11.3 Recent Development
15.12 Invicro. Llc. (A Subsidiary Of Konica Minolta)
15.12.1 Company Snapshot
15.12.2 Revenue Analysis
15.12.3 Product Portfolio
15.12.4 Recent Developments
15.13 Ixico Plc
15.13.1 Company Snapshot
15.13.2 Revenue Analysis
15.13.3 Product Portfolio
15.13.4 Recent Developments
15.14 Quotient Sciences
15.14.1 Company Snapshot
15.14.2 Product Portfolio
15.14.3 Recent Development
15.15 Radiant Sage Llc
15.15.1 Company Snapshot
15.15.2 Product Portfolio
15.15.3 Recent Development
15.16 Wirb-copernicus Group
15.16.1 Company Snapshot
15.16.2 Product Portfolio
15.16.3 Recent Development
15.17 Worldcare Clinical
15.17.1 Company Snapshot
15.17.2 Product Portfolio
15.17.3 Recent Development
16 Questionnaire
17 Related Reports 173
List Of Tables
Table 1 Cost Of Clinical Trial Phase 2 And Phase 3
Table 2 Huge R&D Cost In The U.S. For Different Phases
Table 3 North America Clinical Trial Imaging Market, By Products & Services, 2020-2029 (Usd Million)
Table 4 North America Services In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 5 North America Services In Clinical Trial Imaging Market, By Products & Services, 2020-2029 (Usd Million)
Table 6 North America Software In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 7 North America Clinical Trial Imaging Market, By Modality, 2020-2029 (Usd Million)
Table 8 North America Computed Tomography In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 9 North America Magnetic Resonance Imaging In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 10 North America Echocardiography In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 11 North America Nuclear Medicine In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 12 North America Positron Emission Tomography In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 13 North America X-ray In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 14 North America Ultrasound In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 15 North America Optical Coherence Tomography In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 16 North America Others In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 17 North America Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 18 North America Oncology In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 19 North America Oncology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 20 North America Neurology In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 21 North America Neurology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 22 North America Cardiology In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 23 North America Cardiology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 24 North America Endocrinology In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 25 North America Endocrinology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 26 North America Dermatology In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 27 North America Dermatology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 28 North America Hematology In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 29 North America Hematology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 30 North America Others In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 31 North America Clinical Trial Imaging Market, By End User, 2020-2029 (Usd Million)
Table 32 North America Contract Research Organization In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 33 North America Pharmaceutical And Biotechnology Companies In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 34 North America Medical Device Manufacturers In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 35 North America Academic And Government Research Institutes In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 36 North America Others In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 37 North America Clinical Trial Imaging Market, By Distributor, 2020-2029 (Usd Million)
Table 38 North America Direct Sales In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 39 North America Tender Sales In Clinical Trial Imaging Market, By Region, 2020-2029 (Usd Million)
Table 40 North America Clinical Trial Imaging Market, By Country, 2020-2029 (Usd Million)
Table 41 North America Clinical Trial Imaging Market, By Product & Services, 2020-2029 (Usd Million)
Table 42 North America Services In Clinical Trial Imaging Market, By Product & Services, 2020-2029 (Usd Million)
Table 43 North America Clinical Trial Imaging Market, By Modality, 2020-2029 (Usd Million)
Table 44 North America Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 45 North America Oncology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 46 North America Neurology Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 47 North America Endocrinology In Clinical Trial Imaging Market, By Application,2020-2029 (Usd Million)
Table 48 North America Cardiology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 49 North America Dermatology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 50 North America Hematology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 51 North America Clinical Trial Imaging Market, By End User, 2020-2029 (Usd Million)
Table 52 North America Clinical Trial Imaging Market, By Distributor, 2020-2029 (Usd Million)
Table 53 U.S. Clinical Trial Imaging Market, By Product & Services, 2020-2029 (Usd Million)
Table 54 U.S. Services In Clinical Trial Imaging Market, By Product & Services, 2020-2029 (Usd Million)
Table 55 U.S. Clinical Trial Imaging Market, By Modality, 2020-2029 (Usd Million)
Table 56 U.S. Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 57 U.S. Oncology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 58 U.S. Neurology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 59 U.S. Endocrinology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 60 U.S. Cardiology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 61 U.S. Dermatology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 62 U.S. Hematology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 63 U.S. Clinical Trial Imaging Market, By End User, 2020-2029 (Usd Million)
Table 64 U.S. Clinical Trial Imaging Market, By Distributor, 2020-2029 (Usd Million)
Table 65 Canada Clinical Trial Imaging Market, By Product & Services, 2020-2029 (Usd Million)
Table 66 Canada Services In Clinical Trial Imaging Market, By Product & Services, 2020-2029 (Usd Million)
Table 67 Canada Clinical Trial Imaging Market, By Modality, 2020-2029 (Usd Million)
Table 68 Canada Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 69 Canada Oncology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 70 Canada Neurology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 71 Canada Endocrinology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 72 Canada Cardiology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 73 Canada Dermatology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 74 Canada Hematology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 75 Canada Clinical Trial Imaging Market, By End User, 2020-2029 (Usd Million)
Table 76 Canada Clinical Trial Imaging Market, By Distributor, 2020-2029 (Usd Million)
Table 77 Mexico Clinical Trial Imaging Market, By Product & Services, 2020-2029 (Usd Million)
Table 78 Mexico Services In Clinical Trial Imaging Market, By Product & Services, 2020-2029 (Usd Million)
Table 79 Mexico Clinical Trial Imaging Market, By Modality, 2020-2029 (Usd Million)
Table 80 Mexico Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 81 Mexico Oncology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 82 Mexico Neurology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 83 Mexico Endocrinology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 84 Mexico Cardiology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 85 Mexico Dermatology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 86 Mexico Hematology In Clinical Trial Imaging Market, By Application, 2020-2029 (Usd Million)
Table 87 Mexico Clinical Trial Imaging Market, By End User, 2020-2029 (Usd Million)
Table 88 Mexico Clinical Trial Imaging Market, By Distributor, 2020-2029 (Usd Million)
List Of Figures
Figure 1 North America Clinical Trial Imaging Market: Segmentation
Figure 2 North America Clinical Trial Imaging Market: Data Triangulation
Figure 3 North America Clinical Trial Imaging Market: Droc Analysis
Figure 4 North America Clinical Trial Imaging Market: North America Vs Regional Market Analysis
Figure 5 North America Clinical Trial Imaging Market: Company Research Analysis
Figure 6 North America Clinical Trial Imaging Market: Interview Demographics
Figure 7 North America Clinical Trial Imaging Market: Dbmr Market Position Grid
Figure 8 North America Clinical Trial Imaging Market: Market Application Coverage Grid
Figure 9 North America Clinical Trial Imaging Market: Vendor Share Analysis
Figure 10 North America Clinical Trial Imaging Market: Segmentation
Figure 11 The Increasing Number Of Contract Research Organization And Rising R&D Expenditure Are Expected To Drive The North America Clinical Trial Imaging Market In The Forecast Period Of 2022 To 2029
Figure 12 Services Segment Is Expected To Account For The Largest Share Of The North America Clinical Trial Imaging Market In 2022 & 2029
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North America Clinical Trial Imaging Market
Figure 14 Worldwide Biopharma Companies R&D Expenditure (In Usd Million)
Figure 15 The Market Growth In Clinical Cro (In Usd Millions)
Figure 16 The Function Of Cro
Figure 17 Estimated New Cancer Cases, 2022
Figure 18 Value Of The Pharmaceutical Sector, Worldwide, 2021 By Country (In Million U.S. Dollars)
Figure 19 North America Clinical Trial Imaging Market: By Products & Services, 2021
Figure 20 North America Clinical Trial Imaging Market: By Products & Services, 2022-2029 (Usd Million)
Figure 21 North America Clinical Trial Imaging Market: By Products & Services, Cagr (2022-2029)
Figure 22 North America Clinical Trial Imaging Market: By Products & Services, Lifeline Curve
Figure 23 North America Clinical Trial Imaging Market: By Modality, 2021
Figure 24 North America Clinical Trial Imaging Market: By Modality, 2022-2029 (Usd Million)
Figure 25 North America Clinical Trial Imaging Market: By Modality, Cagr (2022-2029)
Figure 26 North America Clinical Trial Imaging Market: By Modality, Lifeline Curve
Figure 27 North America Clinical Trial Imaging Market: By Application, 2021
Figure 28 North America Clinical Trial Imaging Market: By Application, 2022-2029 (Usd Million)
Figure 29 North America Clinical Trial Imaging Market: By Application, Cagr (2022-2029)
Figure 30 North America Clinical Trial Imaging Market: By Application, Lifeline Curve
Figure 31 North America Clinical Trial Imaging Market: By End User, 2021
Figure 32 North America Clinical Trial Imaging Market: By End User, 2022-2029 (Usd Million)
Figure 33 North America Clinical Trial Imaging Market: By End User, Cagr (2022-2029)
Figure 34 North America Clinical Trial Imaging Market: By End User, Lifeline Curve
Figure 35 North America Clinical Trial Imaging Market: By Distributor, 2021
Figure 36 North America Clinical Trial Imaging Market: By Distributor, 2022-2029 (Usd Million)
Figure 37 North America Clinical Trial Imaging Market: By Distributor, Cagr (2022-2029)
Figure 38 North America Clinical Trial Imaging Market: By Distributor, Lifeline Curve
Figure 39 North America Clinical Trial Imaging Market: Snapshot (2021)
Figure 40 North America Clinical Trial Imaging Market: By Country (2021)
Figure 41 North America Clinical Trial Imaging Market: By Country (2022 & 2029)
Figure 42 North America Clinical Trial Imaging Market: By Country (2021 & 2029)
Figure 43 North America Clinical Trial Imaging Market: By Product And Services (2022-2029)
Figure 44 North America Clinical Trial Imaging Market: Company Share 2021 (%) 125

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings